IONIS PHARMACEUT reported $-85514000 in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Agios Pharmaceuticals AGIO:US $ -97640000 3.5M
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Arrowhead Research ARWR:US $ -72909000 114.46M
Astellas Pharma 4503:JP 32.63B 44.87B
Biocryst Pharmaceuticals BCRX:US $ -34722000 15.24M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Bluebird Bio BLUE:US $ -100761000 19.58M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Exelixis EXEL:US $ 83.71M 463K
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
Mirati Therapeutics MRTX:US $ -177205000 7.01M
Moderna Inc MRNA:US 2.45B 1.78B
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Novartis NOVN:VX 3.32B 176M
Pfizer PFE:US $ 12099M 2104M
Ptc Therapeutics PTCT:US $ -92362000 5.84M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Ultragenyx Pharmaceutical RARE:US $ -141593000 4.96M
Vertex Pharmaceuticals VRTX:US $ 1119.3M 85.9M